Small risk ratios may have strong public health impact

doi:10.1136/bmj.327.7422.1050-c

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Alfonso Carvajal (carvajal@ife.uva.es), professor of pharmacology,
Miguel Angel Maciá, clinical pharmacologist,
Javier García del Pozo, pharmacist,
Francisco de Abajo, head

Instituto de Farmacoepidemiología, Ramán y Cajal, 7, E-47005 Valladolid, Spain
Pharmacovigilance Centre of Castilla-La Mancha, Toledo, Spain
Spanish Medicines Agency, Madrid, Spain

EDITOR—Traversa et al studied the hepatoxicity of nimesulide and other nonsteroidal anti-inflammatory drugs (NSAIDs).1 Nimesulide may arguably have a small risk of the more severe hepatic injuries with an odds ratio of 1.9 (95% confidence interval 1.1 to 3.81). Since the drug is widely used in Italy the population attributable risk could account …